| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |